Quantum BioPharma LtdNASDAQ:QNTMView on Canadian Exchange
- LAST PRICE3.8900
- TODAY'S CHANGE (%)-0.0100 (-0.2564%)
- Bid / Lots3.7200/ 2
- Ask / Lots3.9500/ 1
- Open / Previous Close3.8800 / 3.9000
- Day Range
- 52 Week Range
- Volume25,786
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | QNTM |
|---|---|---|
| 09:32 ET | 3557 | 3.88 |
| 09:34 ET | 927 | 3.9592 |
| 09:41 ET | 890 | 3.905 |
| 09:43 ET | 737 | 3.95 |
| 10:08 ET | 500 | 3.93 |
| 10:12 ET | 149 | 3.88 |
| 10:15 ET | 200 | 3.86 |
| 10:17 ET | 490 | 3.888 |
| 10:21 ET | 300 | 3.93 |
| 10:32 ET | 100 | 3.9 |
| 10:44 ET | 150 | 3.86 |
| 10:46 ET | 1172 | 3.88 |
| 11:11 ET | 1049 | 3.55 |
| 11:13 ET | 472 | 3.5816 |
| 11:15 ET | 2500 | 3.7999 |
| 11:18 ET | 174 | 3.6123 |
| 11:20 ET | 2400 | 3.72 |
| 11:22 ET | 3699 | 3.76 |
| 11:27 ET | 400 | 3.76 |
| 12:00 ET | 1300 | 3.89 |
Sep 9, 2024
Sep 6, 2024
Aug 30, 2024
Quantum BioPharma Ltd. (QNTM) Announces Key Milestones; Price Target $12.80, from 10:31AM ET on Friday Aug 30, 2024 by Dow Jones
10:31AM ET on Friday Aug 30, 2024 by Dow JonesQuantum Biopharma Announces Celly Nutrition Launches unbuzzd(TM) Grab-and-Go Stick Packs on Amazon.com so you can "own NOW and what's NEXT", from 7:32AM ET on Friday Aug 30, 2024 by Dow Jones
7:32AM ET on Friday Aug 30, 2024 by Dow Jones
Aug 15, 2024
*DJ News On FSD Pharma Inc. (HUGE) Now Under QNTM, from 5:08PM ET on Thursday Aug 15, 2024 by Dow Jones
5:08PM ET on Thursday Aug 15, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Quantum BioPharma Ltd | 9.8M | 0.0x | --- |
Company Information
Quantum BioPharma Ltd, formerly FSD Pharma Inc., is a biotechnology company. It operates in two segments: Biotechnology and Strategic Investments. Its Biotechnology segment is focused on furthering the research and development of its two primary drug candidates, consisting of Lucid-MS and Lucid-PSYCH, as well as the development of UNBUZZD. Its Strategic Investments segment is focused on generating returns and cashflow through the issuance of loans secured by residential or commercial real estate property. Lucid-PSYCH is a molecular compound identified for the potential treatment of mental health disorders. Lucid-MS is a molecular compound identified for the potential treatment of neurodegenerative disorders. UNBUZZD is a proprietary formulation of natural ingredients, vitamins, and minerals to help with liver and brain function for the purposes of potentially quickly relieving from the effects of alcohol consumption, such as inebriation, and restoring normal lifestyle.
Contact Information
- Headquarters
- First Canadian Place 100 King Street West, Suite 4000TORONTO, ON, Canada M5X 1A4
- Phone
- 416-854-8884
- Fax
- 416-854-8884
Executives
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $9.8M |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 1.9M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.86 |
EPS | $-18.00 |
Book Value | $29.66 |
P/E Ratio | 0.0x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
